William W Storms
Overview
Explore the profile of William W Storms including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
351
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Storms W, Miller J
Respir Med Case Rep
. 2018 Jul;
24:84-85.
PMID: 29977767
We report improved lung function and quality of life following daily use of guaifenesin/dextromethorphan (Mucinex DM, Reckitt Benckiser) for the treatment of mucus-related symptoms in a patient with COPD, who...
2.
Storms W, Miller J
Respir Med Case Rep
. 2018 May;
23:156-157.
PMID: 29719806
We report an improvement in symptoms and quality of life with long-term use of guaifenesin for the treatment of mucus-related symptoms in a patient with chronic bronchitis, who presented with...
3.
Storms W, Tringale M, Ferro T
Allergy Asthma Proc
. 2015 Apr;
36(4):300-5.
PMID: 25916212
Background: Despite the available treatments, asthma remains a serious illness, with a considerable socioeconomic burden associated with a high number of unscheduled visits to the emergency department (ED). Poor adherence...
4.
Hoyte F, Meltzer E, Ostrom N, Nelson H, Bensch G, Spangler D, et al.
Allergy Asthma Proc
. 2015 Jan;
35 Suppl 1:S20-7.
PMID: 25582158
Allergic rhinitis (AR) affects at least 60 million people in the United States each year, resulting in a major impact on patient quality of life, productivity, and direct and indirect...
5.
Meltzer E, Bensch G, Storms W
Allergy Asthma Proc
. 2015 Jan;
35 Suppl 1:S11-9.
PMID: 25582157
Intranasal corticosteroids (INSs) have been effectively used for >40 years for the treatment of seasonal allergic rhinitis (SAR) and perennial AR (PAR). Following the Montreal Protocol, the initial aerosol formulations...
6.
Weiler J, Hallstrand T, Parsons J, Randolph C, Silvers W, Storms W, et al.
J Allergy Clin Immunol Pract
. 2014 May;
2(3):275-80.e7.
PMID: 24811017
This article summarizes the findings of an expert panel of nationally recognized allergists and pulmonologists who met to discuss how to improve detection and diagnosis of exercise-induced bronchoconstriction (EIB), a...
7.
Storms W, Segall N, Mansfield L, Amar N, Kelley L, Ding Y, et al.
Ann Allergy Asthma Immunol
. 2013 Oct;
111(5):408-414.e1.
PMID: 24125150
Background: Aerosolized intranasal corticosteroid formulations are desirable for many patients with allergic rhinitis (AR), especially children, who wish to avoid the "wet feeling" and "drip down the throat" associated with...
8.
Parsons J, Hallstrand T, Mastronarde J, Kaminsky D, Rundell K, Hull J, et al.
Am J Respir Crit Care Med
. 2013 May;
187(9):1016-27.
PMID: 23634861
Background: Exercise-induced bronchoconstriction (EIB) describes acute airway narrowing that occurs as a result of exercise. EIB occurs in a substantial proportion of patients with asthma, but may also occur in...
9.
Meltzer E, Gross G, Katial R, Storms W
J Fam Pract
. 2012 Feb;
61(2 Suppl):S5-10.
PMID: 22312622
People with allergic rhinitis rate their overall health significantly lower than individuals without nasal allergies. Compared with the general population, more people with AR complain of difficulty getting to sleep,...
10.
Weiler J, Anderson S, Randolph C, Bonini S, Craig T, Pearlman D, et al.
Ann Allergy Asthma Immunol
. 2010 Dec;
105(6 Suppl):S1-47.
PMID: 21167465
No abstract available.